Tissue microarray for high-throughput analysis of gene expression profiles in hepatocellular carcinoma

Area of Science:

• Hepatocellular carcinoma (HCC) research
• Cancer biology
• Molecular oncology

Background:

• Hepatocellular carcinoma (HCC) is a significant global health concern.
• Understanding the molecular mechanisms driving HCC development is crucial for effective treatment strategies.
• Hepatitis B virus (HBV) infection is a major risk factor for HCC, involving viral antigens like HBsAg and HBcAg.

Purpose of the Study:

• To investigate the expression profiles of Hepatitis B surface antigen (HBsAg), Hepatitis B core antigen (HBcAg), p21WAF1/CIP1 (p21), and Retinoblastoma (Rb) proteins in HCC.
• To elucidate the potential roles of these proteins in the process of hepatocarcinogenesis.

Main Methods:

• Construction of a tissue microarray from 40 HCC cases, including cancerous, para-cancerous, and adjacent normal liver tissues.
• Immunohistochemical staining using the streptavidin-peroxidase (S-P) method to detect HBsAg, HBcAg, p21, and Rb protein expression.
• Comparative analysis of protein expression loss in different tissue types and correlation with clinicopathological features.

Main Results:

• Significantly lower positive rates of HBsAg and HBcAg expression were observed in HCC tissues compared to para-cancerous and normal tissues.
• Conversely, higher deletion rates of p21 and Rb proteins were found in HCC tissues.
• p21 protein deletion showed a notable correlation with the pathological grade of HCC, while Rb protein deletion did not significantly correlate with tumor size or pathological grade.

Conclusions:

• The deletion of HBsAg, HBcAg, p21, and Rb protein expression in HCC may play a critical role in hepatocarcinogenesis.
• Tissue microarray technology serves as an effective high-throughput platform for advancing cancer research.